- 米国企業
- AYTU BIOPHARMA, INC
AYTU BIOPHARMA, INCAYTU
時価総額
$1375.2万
PER
| 2013年 8月31日 | 2015年 6月30日 | 2016年 6月30日 | 2017年 6月30日 | 2018年 6月30日 | 2019年 6月30日 | 2020年 6月30日 | 2021年 6月30日 | 2022年 6月30日 | 2023年 6月30日 | |
| Product revenue, net | 5,250 | 261,782 | 3 | 3 | 4 | 7 | 28 | 66 | 97 | 107 |
| Cost of sales | - | - | - | - | - | - | - | - | - | 41 |
| Gross profit | - | - | - | - | - | - | - | 29 | 52 | 67 |
| Selling and marketing | - | - | - | - | - | - | - | 30 | 39 | 41 |
| General and administrative | 341,522 | 4 | - | - | - | - | - | 26 | 31 | 29 |
| Research and development | - | 3 | 6 | 959,857 | 167,595 | 589,072 | 2 | 6 | 14 | 4 |
| Impairment of other assets | - | - | - | - | - | - | - | - | - | 6 |
| Amortization of intangible assets | - | - | 664,707 | 2 | 2 | 2 | 4 | 6 | 4 | 5 |
| Gain from contingent consideration | - | - | - | - | - | - | - | - | 2 | 1 |
| Total operating expenses | 548,532 | - | 24 | 23 | 23 | 24 | 49 | 88 | 164 | 84 |
| Loss from operations | -52,414 | -7,632,320 | -21,704,397 | -20,125,236 | -19,700,234 | -16,846,637 | -21,130,546 | -59 | -112 | -17 |
| Other expense, net | - | - | - | - | - | 80,779 | - | -2 | -1 | -5 |
| Gain on extinguishment of debt | - | - | - | - | - | - | -315,728 | -2 | 0 | - |
| Gain on derivative warrant liability | - | - | -12,572 | 212,809 | 4 | -9,830,550 | 1,830 | - | 0 | 5 |
| Total other income, net | -4,904 | - | -6,475,687 | -2,383,068 | 10 | -10,285,271 | 8 | 1 | 1 | 0 |
| Loss before income tax | - | -7,747,314 | -28,180,084 | - | - | - | - | -58 | -110 | -17 |
| Income tax benefit | - | -23,910 | - | - | - | - | - | 0 | -0 | - |
| Net loss | -57,318 | -7,723,404 | -28,180,084 | -22,508,304 | -10,187,863 | -27,131,908 | -13,620,679 | -58 | -110 | -17 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - | - | -3.39 | -5.11 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | -3.75 | -5.11 |